SPRO
#3879
Spero Therapeutics, Inc. - Common Stock
2.1 8 USD
+0.04%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.81%
Variación mensual
-25.60%
Variación en los últimos 6 meses
-12.80%
Cambio anual
-16.48%
Cierres anteriores
2.1 0
Open
2.1 8
Mínimo
2.1 8
High
2.1 8
Volumen
17
Financials
- Market Capitalization 126.23 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
8.67
Relación precio/flujo de caja
2.22
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3866 |  GNLX Genelux Corporation - Common Stock | 2.96 USD | -2.31% | -1.66% | -1.66% | -12.17% | 132.73 M USD | ||
| 3871 |  AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 USD | -21.58% | +1.36% | +52.82% | -52.74% | 130.03 M USD | ||
| 3884 |  CUE Cue Biopharma, Inc. - Common Stock | 30.92 USD | -15.93% | -5.93% | +26.05% | +3968.42% | 125.09 M USD | ||
| 3885 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.86 USD | -2.11% | -2.62% | +6.29% | -77.86% | 124.60 M USD |